1834 Investment Advisors Co. Sells 525 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

1834 Investment Advisors Co. cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,877 shares of the medical equipment provider’s stock after selling 525 shares during the period. 1834 Investment Advisors Co.’s holdings in Intuitive Surgical were worth $922,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Creekmur Asset Management LLC lifted its stake in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the period. Ridgewood Investments LLC bought a new stake in Intuitive Surgical in the second quarter worth approximately $26,000. Delos Wealth Advisors LLC lifted its stake in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the period. Godsey & Gibb Inc. boosted its holdings in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. Finally, LRI Investments LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 240 shares of Intuitive Surgical stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,558,968.56. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 68,246 shares of company stock valued at $33,839,308 in the last 90 days. 0.80% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on ISRG. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Mizuho increased their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Citigroup boosted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Finally, Leerink Partners increased their price target on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Price Performance

ISRG opened at $515.17 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $269.49 and a fifty-two week high of $523.34. The firm has a market capitalization of $183.49 billion, a P/E ratio of 82.82, a PEG ratio of 4.98 and a beta of 1.39. The company’s 50-day moving average is $491.63 and its 200 day moving average is $449.59.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.